Scinovex
article Open Access

Assessment of short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of conjunctivitis

International Journal of Advanced Research in Medicine · 2021 · Vol. 3(2) · pp. 88–90

Abstract

Background: Acute and chronic superficial ocular inflammation of bacterial origin is a common problem characterized by irritation, itching, and burning of the eyelids. The present study was conducted to assess short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of conjunctivitis. Materials & Methods: 68 patients of conjunctivitis of both genders were divided into 2 groups of 34 each. Group I patients were given combination of neomycin sulphate 3500 lU/mL, polymyxin-B sulphate 6000 lU/mL with dexamethasone 0.1% and group II were given 0.1% dexamethasone. The symptoms evaluated included foreign body sensation, lacrimation, photophobia, and itching. Materials & Methods: 68 patients of conjunctivitis of both genders were divided into 2 groups of 34 each. Group I patients were given combination of neomycin sulphate 3500 lU/mL, polymyxin-B sulphate 6000 lU/mL with dexamethasone 0.1% and group II were given 0.1% dexamethasone. The symptoms evaluated included foreign body sensation, lacrimation, photophobia, and itching. Conclusion: Use of a fixed dose combination steroid-antibiotic product was more effective for bacterial control and therapeutic efficacy in the treatment of conjunctivitis.

Ocular Infections and TreatmentsOcular Surface and Contact LensIntraocular Surgery and LensesPhotophobiaDexamethasoneItchingMedicineAntibioticsTopical steroidAllergic conjunctivitisNeomycinSteroidDermatology
Citations
0
FWCI
0.00
field-weighted impact
References
12
Percentile
15%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Assessment of short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of conjunctivitis · Scinovex